Beiersdorf Aktiengesellschaft
5-year stock timeline
Beiersdorf navigated the 2020 COVID shock with a moderate drawdown relative to peers, closing the year around €94.44 after a volatile recovery buoyed by lockdown dynamics and vaccine developments.
From 2021 through 2023, the company executed a genuine recovery into above-market organic growth. Record 2023 sales of roughly €9.5bn and double-digit organic expansion followed, while management pursued a multi-driver growth strategy and raised the dividend to €1.00—a signal of strengthening cash generation.
The 2024–2025 period brought ownership and governance into sharper focus as anchor shareholder Maxingvest solidified decisive control. Late-2025 demand softness and guidance downgrades then forced the market to reassess operations and valuation.
Through 2020 and 2021, the stock carried a defensive consumer compounder label—stable, recognizable brands paired with relative resilience through pandemic volatility. That narrative shifted in 2022–2023 toward profitable growth and premiumization as results and organic momentum improved, lifting sentiment among growth-oriented holders.
By 2024 and into 2026, investor views diverged. Some emphasized the stability anchored by Maxingvest's backing, while others flagged medium-term demand risks and valuation exposure following the renewed guidance cuts.
March 2020 delivered a sharp market-wide selloff and material dip for Beiersdorf, followed by recovery into the €90–€100 range by year-end as sentiment normalized. The 2021–2023 period saw an extended uptrend with several strong rallies tracking improving fundamentals and the 2023 record sales and dividend surprise.
Since 2024 through May 2026, the chart has consolidated with lower highs and renewed volatility around late-2025 guidance cuts and ownership headlines. The current price sits at 73.24, with the 2025 guidance revision remaining a clear technical and sentiment inflection point.
Key risks and downside factors
Beiersdorf operates in mass and premium skincare where it faces formidable competitors in L'Oréal, Unilever, Procter & Gamble, and Estée Lauder—companies large enough to exert real pressure on pricing, shelf space, and R&D spending [3]. The tesa adhesives business provides portfolio ballast against skincare cycles but introduces its own headwinds: industrial demand swings and raw material cost volatility [3].
- Larger FMMCG rivals are applying margin pressure through aggressive pricing, which risks eroding both Nivea's volumes and earnings.
- Inability to keep pace with premiumization and R&D-led innovation means prestige competitors can capture higher-margin growth [3].
- Exposure to supply-chain dynamics, raw-material costs, and industrial cycles—tesa's adhesive business tracks closely with commodity inputs and swings in electronics and EV demand.
- Currency fluctuations and emerging-market dynamics create meaningful headwinds. Slower growth or tightening regulations across Asia-Pacific and emerging markets can introduce real volatility into sales, particularly when these regions represent significant revenue exposure.
Competitive landscape
Beiersdorf AG (BEI.XETRA) is a German consumer-goods company built around skincare and personal-care brands with substantial international reach. The business operates in a densely competitive landscape—up against large global consumer-goods and cosmetics players—while managing margin pressure from input costs, logistics, and currency movements, plus the ongoing compliance burden of regulatory and ingredient requirements.
| Company | Ticker |
|---|---|
| L'Oréal S.A. | OR.PA |
| The Procter & Gamble Company | PG.NYSE |
| Henkel AG & Co. KGaA | HEN3.XETRA |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialPerformance Figures of Beiersdorf Aktiengesellschaft
Relative Performance vs Benchmarks
| Period | Beiersdorf Aktiengesellschaft | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +1.41% | -2.85% | -4.04% |
| 3M | -31.03% | -30.07% | -40.73% |
| 6M | -19.88% | -24.94% | -30.32% |
| 1Y | -38.39% | -42.57% | -67.54% |
| 3Y | -39.15% | -96.13% | -124.82% |
| 5Y | -21.44% | -82.80% | -112.74% |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHistorical valuation trends
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 24.1 | 2.2 | 1.9 | 19.5 |
| 1Y ago | 16.6 | 1.4 | 3.2 | 12.2 |
| 3Y ago | 24.8 | 2.1 | 14.4 | 35.3 |
| 5Y ago | 25.4 | 2.1 | 12.8 | 13.8 |
Frequently Asked Questions
Where is the Beiersdorf Aktiengesellschaft stock traded?
What does Beiersdorf Aktiengesellschaft do?
What are the key metrics for BEI.XETRA?
How has Beiersdorf Aktiengesellschaft's stock price performed?
How is BEI.XETRA valued?
Does BEI.XETRA pay dividends?
What are the key risks when investing in BEI.XETRA?
- Larger FMMCG rivals are applying margin pressure through aggressive pricing, which risks eroding both Nivea's volumes and earnings.
- Inability to keep pace with premiumization and R&D-led innovation means prestige competitors can capture higher-margin growth [web:3].
- Exposure to supply-chain dynamics, raw-material costs, and industrial cycles—tesa's adhesive business tracks closely with commodity inputs and swings in electronics and EV demand.
- Currency fluctuations and emerging-market dynamics create meaningful headwinds. Slower growth or tightening regulations across Asia-Pacific and emerging markets can introduce real volatility into sales, particularly when these regions represent significant revenue exposure.
Who are the main competitors of Beiersdorf Aktiengesellschaft?
- L'Oréal S.A. (OR.PA)
- The Procter & Gamble Company (PG.NYSE)
- Henkel AG & Co. KGaA (HEN3.XETRA)
When does Beiersdorf Aktiengesellschaft report earnings?
Key Metrics
Valuation Metrics
Profitability Metrics
Growth Metrics
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 1.00 EUR | 1.35% | 0.88% |
| 2025 | 1.00 EUR | 0.84% | |
| 2024 | 1.00 EUR | 0.74% | |
| 2023 | 0.70 EUR | 0.57% | |
| 2022 | 0.70 EUR | 0.74% | |
| 2021 | 0.70 EUR | 0.78% | |
| 2020 | 0.70 EUR | 0.74% | |
| 2019 | 0.70 EUR | 0.76% | |
| 2018 | 0.70 EUR | 0.76% | |
| 2017 | 0.70 EUR | 0.77% | |
| 2016 | 0.70 EUR | 0.88% | |
| 2015 | 0.70 EUR | 0.87% | |
| 2014 | 0.70 EUR | 0.99% | |
| 2013 | 0.70 EUR | 1.03% | |
| 2012 | 0.70 EUR | 1.33% |
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
Upcoming earnings report
Analyst estimates for upcoming periods
Key financial figures
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 9.85B | 9.85B | 9.45B | 8.80B | 7.63B |
| Operating income (EBIT) | 1.35B | 1.30B | 1.10B | 1.22B | 980.00M |
| Net income | 939.00M | 912.00M | 736.00M | 755.00M | 638.00M |
| Free cash flow | 373.00M | 794.00M | 424.00M | 249.00M | 580.00M |
| Total assets | 12.85B | 13.01B | 12.63B | 12.35B | 11.30B |
| Equity | 8.60B | 8.47B | 8.32B | 7.79B | 6.87B |
| Net debt | -983.00M | -941.00M | -1.03B | -722.00M | -757.00M |
PWP Leeway UG (haftungsbeschränkt)
